Search Results - Xuhui Bao

  • Showing 1 - 12 results of 12
Refine Results
  1. 1
    Targeting purinergic pathway to enhance radiotherapy-induced immunogenic cancer cell death

    Targeting purinergic pathway to enhance radiotherapy-induced immunogenic cancer cell death by Xuhui Bao, Liyi Xie

    Published 2022
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    SETDB1 Restrains Endogenous Retrovirus Expression and Antitumor Immunity during Radiotherapy

    SETDB1 Restrains Endogenous Retrovirus Expression and Antitumor Immunity during Radiotherapy by Dong Pan, Xuhui Bao, Mengjie Hu, Meng Jiao, Fang Li, Chuan‐Yuan Li

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Endogenous Retrovirus Activation as a Key Mechanism of Anti-Tumor Immune Response in Radiotherapy

    Endogenous Retrovirus Activation as a Key Mechanism of Anti-Tumor Immune Response in Radiotherapy by Andrew K. Lee, Dong Pan, Xuhui Bao, Mengjie Hu, Fang Li, Chuan‐Yuan Li

    Published 2020
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    ATM inhibition enhances cancer immunotherapy by promoting mtDNA leakage and cGAS/STING activation

    ATM inhibition enhances cancer immunotherapy by promoting mtDNA leakage and cGAS/STING activation by Mengjie Hu, Min Zhou, Xuhui Bao, Dong Pan, Meng Jiao, Xinjian Liu, Fang Li, Chuan‐Yuan Li

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Bacterial‐Mediated Tumor Therapy: Old Treatment in a New Context

    Bacterial‐Mediated Tumor Therapy: Old Treatment in a New Context by Yao Liu, Lili Niu, Nannan Li, Yang Wang, Mingyang Liu, Xiaomin Su, Xuhui Bao, Bo Yin, Shun Shen

    Published 2023
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside

    Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside by Xuhui Bao, Yongjun Liang, Hanman Chang, Tianji Cai, Baijie Feng, Константин Гордон, Yuekun Zhu, Hailian Shi, Yundong He, Liyi Xie

    Published 2024
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  7. 7
    Inhibition of PCSK9 potentiates immune checkpoint therapy for cancer

    Inhibition of PCSK9 potentiates immune checkpoint therapy for cancer by Xinjian Liu, Xuhui Bao, Mengjie Hu, Hanman Chang, Meng Jiao, Jin Cheng, Liyi Xie, Qian Huang, Fang Li, Chuan‐Yuan Li

    Published 2020
    Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Recombinant anti‐podoplanin (NZ‐1) immunotoxin for the treatment of malignant brain tumors

    Recombinant anti‐podoplanin (NZ‐1) immunotoxin for the treatment of malignant brain tumors by Vidyalakshmi Chandramohan, Xuhui Bao, Mika K. Kaneko, Yukinari Kato, Stephen T. Keir, Scott E. Szafranski, Chien‐Tsun Kuan, Ira Pastan, Darell D. Bigner

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Construction of an Immunotoxin, D2C7-(scdsFv)-PE38KDEL, Targeting EGFRwt and EGFRvIII for Brain Tumor Therapy

    Construction of an Immunotoxin, D2C7-(scdsFv)-PE38KDEL, Targeting EGFRwt and EGFRvIII for Brain Tumor Therapy by Vidyalakshmi Chandramohan, Xuhui Bao, Stephen T. Keir, Charles N. Pegram, Scott E. Szafranski, Hailan Piao, Carol J. Wikstrand, Roger E. McLendon, Chien‐Tsun Kuan, Ira Pastan, Darell D. Bigner

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Improved efficacy against malignant brain tumors with EGFRwt/EGFRvIII targeting immunotoxin and checkpoint inhibitor combinations

    Improved efficacy against malignant brain tumors with EGFRwt/EGFRvIII targeting immunotoxin and checkpoint inhibitor combinations by Vidya Chandramohan, Xuhui Bao, Xin Yu, Scott Parker, Charlotte McDowall, Yen-Rei Andrea Yu, Patrick Healy, Annick Desjardins, Michael D. Gunn, Matthias Gromeier, Smita K. Nair, Ira Pastan, Darell D. Bigner

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    XIAP Regulation by MNK Links MAPK and NFκB Signaling to Determine an Aggressive Breast Cancer Phenotype

    XIAP Regulation by MNK Links MAPK and NFκB Signaling to Determine an Aggressive Breast Cancer Phenotype by Myron K. Evans, Michael C. Brown, Joseph Geradts, Xuhui Bao, Timothy J. Robinson, Mohit Kumar Jolly, Peter Vermeulen, Gregory M. Palmer, Matthias Gromeier, Herbert Levine, Michael A. Morse, Steven Van Laere, Gayathri R. Devi

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    KMT2D maintains neoplastic cell proliferation and global histone H3 lysine 4 monomethylation

    KMT2D maintains neoplastic cell proliferation and global histone H3 lysine 4 monomethylation by Changcun Guo, Lee H. Chen, Yafen Huang, Chun‐Chi Chang, Ping Wang, Christopher J. Pirozzi, Xiaoxia Qin, Xuhui Bao, Paula K. Greer, Roger E. McLendon, Hai Yan, Stephen T. Keir, Darell D. Bigner, Yiping He

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: